Korean J Clin Pharm.  2017 Mar;27(1):1-8. 10.24304/kjcp.2017.27.1.1.

Development of a Pharmaceutical Care Service Model for Patients with Diabetes in Ambulatory Care Settings

• Yoon JH

• KMID: 2377533
• DOI: http://doi.org/10.24304/kjcp.2017.27.1.1

Abstract

The prevalence of diabetes and its related morbidity and mortality are being increased. Despite the advancement of evidence-based pharmacotherapy in the management of diabetes, many patients in our country do not achieve satisfied therapeutic outcomes. Pharmaceutical care service can be defined as a patient-centered clinical service provided by pharmacists to improve therapeutic outcomes and quality of life of patients, by identifying, and preventing or resolving drug-related problems (DRPs). Pharmaceutical care service is interdisciplinary team-based practice, and is provided through collaborative practice agreement (CPA) between one or more physicians and pharmacists. This article describes a model of pharmaceutical care service which can be adopted in our country for patients with diabetes in the ambulatory care settings. With the successful implementation of this service, clinical, economic, and humanistic outcomes of patients will be improved. Therefore, by actively implementing pharmaceutical care service, pharmacist should contribute to the promotion of patients' health and to the advancement of health care delivery system.

Keyword

Pharmaceutical care; diabetes; service; ambulatory; team-based

MeSH Terms

Ambulatory Care*
Delivery of Health Care
Drug Therapy
Humans
Mortality
Pharmaceutical Services*
Pharmacists
Prevalence
Quality of Life